Monitoring dynamic cytotoxic chemotherapy response in castration-resistant prostate cancer using plasma cell-free DNA (cfDNA)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Monitoring dynamic cytotoxic chemotherapy response in castration-resistant prostate cancer using plasma cell-free DNA (cfDNA) ; volume:12 ; number:1 ; day:15 ; month:5 ; year:2019 ; pages:1-7 ; date:12.2019
BMC Research Notes / Biomed Central; 12, Heft 1 (15.5.2019), 1-7, 12.2019
- Creator
-
Patsch, Katherin
Matasci, Naim
Soundararajan, Anjana
Diaz, Patricia
Agus, David B.
Ruderman, Daniel
Gross, Mitchell E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13104-019-4312-2
- URN
-
urn:nbn:de:101:1-2019112821320223713532
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Patsch, Katherin
- Matasci, Naim
- Soundararajan, Anjana
- Diaz, Patricia
- Agus, David B.
- Ruderman, Daniel
- Gross, Mitchell E.
- SpringerLink (Online service)
Other Objects (12)
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer
Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer
Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage
Targeting molecular resistance in castration-resistant prostate cancer
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
Osteoclasts directly influence castration-resistant prostate cancer cells
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Towards systematic nomenclature for cell-free DNA
Effect of simvastatin on castration-resistant prostate cancer cells
Ureter metastatic castration-resistant prostate cancer: a case report
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer
Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer
Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage
Targeting molecular resistance in castration-resistant prostate cancer
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
Osteoclasts directly influence castration-resistant prostate cancer cells
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Towards systematic nomenclature for cell-free DNA
Effect of simvastatin on castration-resistant prostate cancer cells
Ureter metastatic castration-resistant prostate cancer: a case report
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer
Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer
Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage
Targeting molecular resistance in castration-resistant prostate cancer
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
Osteoclasts directly influence castration-resistant prostate cancer cells
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Towards systematic nomenclature for cell-free DNA
Effect of simvastatin on castration-resistant prostate cancer cells
Ureter metastatic castration-resistant prostate cancer: a case report